Wayland
Mark Wayland, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20140368276 | SELF-BIASED RECEIVER - A receiver is disclosed. The receiver includes an amplifier and a bias circuit configured to provide a bias current to the amplifier. The bias circuit is self biasing. The bias circuit is also configured to adjust the bias current using positive feedback from the amplifier. | 12-18-2014 |
Matthew Thomas Wayland, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090093430 | Biomarkers and methods for identification of agents useful in the treatment of affective disorders - Potential therapeutic, agent for the prevention, treatment or amelioration of an affective disorder, such as a bipolar disorder, depression or anxiety disorder are identified. Also provided are methods for diagnosing and monitoring affective disorders. The methods are based on changes in expression of one or more genes that are differentially expressed in affective disorders. | 04-09-2009 |
Richard Wayland, Leonard Town, MD US
Patent application number | Description | Published |
---|---|---|
20100034054 | Enviromentally Assisted Processor in Sonar - An environmentally assisted processor that includes an environmental characterization module, an echo prediction module and an acoustic consistency module. The environmental characterization module obtains surrounding environmental characteristics, and provides inputs of the surrounding environmental characteristics to the echo prediction module. The echo prediction module utilizes the surrounding environmental characteristics to predict echo waveforms of would be targets in that particular local environment. The acoustic consistency module compares an observed echo waveform with predicted echo waveforms, if they are similar the observed echo waveform is determined to be from a target. | 02-11-2010 |
Ruth Wayland, Nantwich GB
Patent application number | Description | Published |
---|---|---|
20110064814 | STABLE PHARMACEUTICAL PRODUCTS - Provided herein is a stable pharmaceutical product comprising a dry powder inhalation device, and a pharmaceutical composition that comprises R,R-Formoterol L-tartrate salt, in particular crystalline R,R-formoterol L-tartrate; and ciclesonide. | 03-17-2011 |
Sarah Wayland, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20080293930 | 3' end tagged oligonucleotides - The present invention provides compositions comprising oligonucleotides that have 3′ end groups (e.g. lipophilic moieties) that are useful in invasive cleavage reactions such as the INVADER assay. Specifically, the present invention provides compositions containing oligonucleotides with 3′ end groups configured for generating a detectable signal in invasive cleavages assays with a high signal-to-background ratio, as well as methods for generating such compositions. | 11-27-2008 |
Sarah R. Wayland, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20090078574 | CHARGE TAGS AND THE SEPARATION OF NUCLEIC ACID MOLECULES - The present invention relates to novel phosphoramidites, including positive and neutrally charged compounds. The present invention also provides charge tags for attachment to materials including solid supports and nucleic acids, wherein the charge tags increase or decrease the net charge of the material. The present invention further provides methods for separating and characterizing molecules based on the charge differentials between modified and unmodified materials. | 03-26-2009 |
20100152431 | COMPOSITIONS, PROBES AND CONJUGATES AND USES THEREOF - The present invention relates to compositions useful as probes and in other applications and methods of their use. In some embodiments, nucleotides are prepared and functionalized with dyes. In some embodiments a first molecule is functionalized with an alkynyl group, a second molecule is functionalized with an azide group, and said first and second molecules are mixed under conditions to form a conjugate with a 1,2,3-triazol group. In further embodiments, a nucleotide is functionalized with an alkynyl group, a dye is functionalized with an azide group, and mixing the nucleotide and the dye forms a conjugate capable of emitting light. | 06-17-2010 |
20120010395 | COMPOSITIONS, PROBES, AND CONJUGATES AND USES THEREOF - The present invention relates to compositions useful as probes and in other applications and methods of their use. In some embodiments, nucleotides are prepared and functionalized with dyes. In some embodiments a first molecule is functionalized with an alkynyl group, a second molecule is functionalized with an azide group, and said first and second molecules are mixed under conditions to form a conjugate with a 1,2,3-triazol group. In further embodiments, a nucleotide is functionalized with an alkynyl group, a dye is functionalized with an azide group, and mixing the nucleotide and the dye forms a conjugate capable of emitting light. | 01-12-2012 |